点击上方蓝字,关注更多精彩9月21日,中国睡眠医学发展论坛在京召开,多位院士、临床专家与国际学者齐聚,发布失眠治疗新数据、新方法、新举措。2023年“科学突破奖”成果揭示的食欲素调控机制,让双食欲素受体拮抗剂(DORA)成为破局关键,获权威指南A级推荐。在此赛道上,先声药业抢先发力,通过与Idorsia合作拿下达利雷生大中华区权益,该药作为欧洲获批的DORA类药物,实现夜间睡眠改善与日间功能提升的...
Source Link点击上方蓝字,关注更多精彩9月21日,中国睡眠医学发展论坛在京召开,多位院士、临床专家与国际学者齐聚,发布失眠治疗新数据、新方法、新举措。2023年“科学突破奖”成果揭示的食欲素调控机制,让双食欲素受体拮抗剂(DORA)成为破局关键,获权威指南A级推荐。在此赛道上,先声药业抢先发力,通过与Idorsia合作拿下达利雷生大中华区权益,该药作为欧洲获批的DORA类药物,实现夜间睡眠改善与日间功能提升的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.